Sarah M. Chu, MSN, AGNP
Sarah Chu is an adult nurse practitioner engaged in clinical research at Massachusetts General Hospital. Her research interests include the mechanisms by which systemic immune activation and inflammation influence cardiovascular health amongst special populations, particularly women with HIV. Ms. Chu has helped lead an NIH-R01 funded study on this theme and other studies on whether statin therapy helps preserve diastolic function among people with HIV. She currently serves as the project manager for the REPRIEVE trial—a randomized placebo-controlled trial that assessed whether pitavastatin vs. placebo can prevent cardiovascular disease in people living with HIV.
In addition to conducting clinical research, she is a member of the MGH Clinical Research Nurse Collaborative. Ms. Chu has received the MGH Pillar of Excellence Award and is a dedicated volunteer health educator at different Boston HIV community service organizations.